Evidence check: TCF7L2 in the context of Abnehmen

TCF7L2 is a well-established gene for type 2 diabetes risk, but its role in weight loss is less clear. Some studies (e.g., from DIETFITS or POUNDS LOST) suggest an interaction with macronutrient composition: risk allele carriers may lose slightly more weight on a low-fat diet compared to a low-carb diet. However, effect sizes are small (around 0.5–1 kg difference) and not clinically decisive. The evidence comes from post-hoc analyses of RCTs and observational data, not from prospective trials designed for weight loss. Therefore, its utility for individual dietary advice is limited. Established factors like calorie balance, physical activity, and behavior change remain far more important. A single TCF7L2 test alone does not provide actionable guidance for weight loss.